159 related articles for article (PubMed ID: 2588122)
1. Selective postoperative radioactive iodine treatment of thyroid carcinoma.
McHenry C; Jarosz H; Davis M; Barbato AL; Lawrence AM; Paloyan E
Surgery; 1989 Dec; 106(6):956-8; discussion 958-9. PubMed ID: 2588122
[TBL] [Abstract][Full Text] [Related]
2. Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
Chu KP; Baker S; Zenke J; Morad A; Ghosh S; Morrish DW; McEwan AJBS; Williams DC; Severin D; McMullen TPW
Thyroid; 2018 Jul; 28(7):902-912. PubMed ID: 29742993
[TBL] [Abstract][Full Text] [Related]
3. [Long-term course in differentiated thyroid gland carcinoma].
Rösler H; Birrer A; Lüscher D; Kinser J
Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
[TBL] [Abstract][Full Text] [Related]
4. The use of radioactive iodine in thyroid carcinoma.
Goolden AW
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):339-43. PubMed ID: 3281849
[TBL] [Abstract][Full Text] [Related]
5. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
Lin JD; Tsang NM; Huang MJ; Weng HF
Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
[TBL] [Abstract][Full Text] [Related]
6. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
9. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?
Proye CA; Dromer DH; Carnaille BM; Gontier AJ; Goropoulos A; Carpentier P; Lefebvre J; Decoulx M; Wemeau JL; Fossati P
World J Surg; 1992; 16(4):640-5; discussion 645-6. PubMed ID: 1384244
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
11. [Recurrences and metastases in differentiated thyroid cancer].
Petkov R
Khirurgiia (Sofiia); 1995; 48(2):8-10. PubMed ID: 8531449
[TBL] [Abstract][Full Text] [Related]
12. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
Rubello D; Mazzarotto R; Casara D
Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
[TBL] [Abstract][Full Text] [Related]
13. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
Lin JD; Chao TC; Huang MJ; Weng HF; Tzen KY
Am J Clin Oncol; 1998 Feb; 21(1):77-81. PubMed ID: 9499265
[TBL] [Abstract][Full Text] [Related]
14. Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.
Hamming JF; van de Velde CJ; Goslings BM; Fleuren GJ; Hermans J; Delemarre JF; van Slooten EA
Surg Gynecol Obstet; 1989 Aug; 169(2):107-14. PubMed ID: 2667172
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine therapy of thyroid disease.
Beierwaltes WH
Int J Rad Appl Instrum B; 1987; 14(3):177-81. PubMed ID: 3312117
[TBL] [Abstract][Full Text] [Related]
16. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.
Pacini F; Cetani F; Miccoli P; Mancusi F; Ceccarelli C; Lippi F; Martino E; Pinchera A
World J Surg; 1994; 18(4):600-4. PubMed ID: 7725751
[TBL] [Abstract][Full Text] [Related]
17. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
18. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma.
Mazzaferri EL
Thyroid; 1997 Apr; 7(2):265-71. PubMed ID: 9133698
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prophylactic postoperative 131I therapy for extended differentiated carcinoma of the thyroid gland.
Nagahara K; Yoza T; Naito Y; Konishi J; Fujita N
Auris Nasus Larynx; 1985; 12 Suppl 2():S67-71. PubMed ID: 3836658
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
